Skip to main content
Erschienen in: Somnologie 4/2019

26.08.2019 | Leserbriefe

Obstructive sleep apnea and cardiovascular disease: a cause more silent than apparent?

verfasst von: Dr. Sven Stieglitz, Hans Jürgen Heppner, Antonio Esquinas

Erschienen in: Somnologie | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Excerpt

This reply refers to Biener L, Pizarro C, Nickenig G, Skowasch D (2019) Obstructive sleep apnea and cardiovascular disease: a cause apparent but not yet evident. Somnologie. https://​doi.​org/​10.​1007/​s11818-019-0212-x
Literatur
1.
Zurück zum Zitat Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290–1297CrossRef Savransky V, Nanayakkara A, Li J, Bevans S, Smith PL, Rodriguez A et al (2007) Chronic intermittent hypoxia induces atherosclerosis. Am J Respir Crit Care Med 175(12):1290–1297CrossRef
2.
Zurück zum Zitat Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618CrossRef Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172(5):613–618CrossRef
3.
Zurück zum Zitat Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712CrossRef Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi GF (2007) Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176(7):706–712CrossRef
4.
Zurück zum Zitat Xie C, Zhu R, Tian Y, Wang K (2017) Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open 7(12):e13983CrossRef Xie C, Zhu R, Tian Y, Wang K (2017) Association of obstructive sleep apnoea with the risk of vascular outcomes and all-cause mortality: a meta-analysis. BMJ Open 7(12):e13983CrossRef
5.
Zurück zum Zitat Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214CrossRef Gami AS, Howard DE, Olson EJ, Somers VK (2005) Day-night pattern of sudden death in obstructive sleep apnea. N Engl J Med 352(12):1206–1214CrossRef
6.
Zurück zum Zitat Mansukhani MP, Wang S, Somers VK (2015) Sleep, death, and the heart. Am J Physiol Heart Circ Physiol 309(5):H739–H749CrossRef Mansukhani MP, Wang S, Somers VK (2015) Sleep, death, and the heart. Am J Physiol Heart Circ Physiol 309(5):H739–H749CrossRef
7.
Zurück zum Zitat Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73CrossRef Becker HF, Jerrentrup A, Ploch T, Grote L, Penzel T, Sullivan CE et al (2003) Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107(1):68–73CrossRef
8.
Zurück zum Zitat Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25):3173–3180CrossRef Arzt M, Floras JS, Logan AG, Kimoff RJ, Series F, Morrison D et al (2007) Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115(25):3173–3180CrossRef
9.
Zurück zum Zitat Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H et al (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719CrossRef Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H et al (2007) Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep 30(6):711–719CrossRef
10.
Zurück zum Zitat Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E (2016) Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with Nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194(5):613–620CrossRef Peker Y, Glantz H, Eulenburg C, Wegscheider K, Herlitz J, Thunstrom E (2016) Effect of positive airway pressure on cardiovascular outcomes in coronary artery disease patients with Nonsleepy obstructive sleep apnea. The RICCADSA randomized controlled trial. Am J Respir Crit Care Med 194(5):613–620CrossRef
11.
Zurück zum Zitat McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931CrossRef McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X et al (2016) CPAP for prevention of cardiovascular events in obstructive sleep apnea. N Engl J Med 375(10):919–931CrossRef
12.
Zurück zum Zitat Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 71(19):e127–e248CrossRef Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C et al (2018) 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American college of cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 71(19):e127–e248CrossRef
13.
Zurück zum Zitat Borgel J, Springer S, Ghafoor J, Arndt D, Duchna HW, Barthel A et al (2010) Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol 99(8):499–506CrossRef Borgel J, Springer S, Ghafoor J, Arndt D, Duchna HW, Barthel A et al (2010) Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: prevalence and co-prevalence. Clin Res Cardiol 99(8):499–506CrossRef
14.
Zurück zum Zitat Zhou X, Liu F, Zhang W, Wang G, Guo D, Fu W et al (2018) Obstructive sleep apnea and risk of aortic dissection: a meta-analysis of observational studies. Vascular 26(5):515–523CrossRef Zhou X, Liu F, Zhang W, Wang G, Guo D, Fu W et al (2018) Obstructive sleep apnea and risk of aortic dissection: a meta-analysis of observational studies. Vascular 26(5):515–523CrossRef
15.
Zurück zum Zitat Braga B, Poyares D, Cintra F, Guilleminault C, Cirenza C, Horbach S et al (2009) Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 10(2):212–216CrossRef Braga B, Poyares D, Cintra F, Guilleminault C, Cirenza C, Horbach S et al (2009) Sleep-disordered breathing and chronic atrial fibrillation. Sleep Med 10(2):212–216CrossRef
16.
Zurück zum Zitat Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y et al (2013) Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 10(3):331–337CrossRef Naruse Y, Tada H, Satoh M, Yanagihara M, Tsuneoka H, Hirata Y et al (2013) Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm 10(3):331–337CrossRef
17.
Zurück zum Zitat Fox H, Bitter T, Horstkotte D, Oldenburg O (2016) Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea. Clin Res Cardiol 105(5):451–459CrossRef Fox H, Bitter T, Horstkotte D, Oldenburg O (2016) Cardioversion of atrial fibrillation or atrial flutter into sinus rhythm reduces nocturnal central respiratory events and unmasks obstructive sleep apnoea. Clin Res Cardiol 105(5):451–459CrossRef
18.
Zurück zum Zitat Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367CrossRef Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE et al (2004) Association of atrial fibrillation and obstructive sleep apnea. Circulation 110(4):364–367CrossRef
19.
Zurück zum Zitat Neilan TG, Farhad H, Dodson JA, Shah RV, Abbasi SA, Bakker JP et al (2013) Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2(6):e421CrossRef Neilan TG, Farhad H, Dodson JA, Shah RV, Abbasi SA, Bakker JP et al (2013) Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc 2(6):e421CrossRef
20.
Zurück zum Zitat Matiello M, Nadal M, Tamborero D, Berruezo A, Montserrat J, Embid C et al (2010) Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 12(8):1084–1089CrossRef Matiello M, Nadal M, Tamborero D, Berruezo A, Montserrat J, Embid C et al (2010) Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace 12(8):1084–1089CrossRef
21.
Zurück zum Zitat Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA et al (2018) The combination of Atomoxetine and Oxybutynin greatly reduces obstructive sleep apnea severity: a randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med 199(10):1267–1276. https://doi.org/10.1164/rccm.201808-1493OC CrossRef Taranto-Montemurro L, Messineo L, Sands SA, Azarbarzin A, Marques M, Edwards BA et al (2018) The combination of Atomoxetine and Oxybutynin greatly reduces obstructive sleep apnea severity: a randomized, placebo-controlled, double-blind crossover trial. Am J Respir Crit Care Med 199(10):1267–1276. https://​doi.​org/​10.​1164/​rccm.​201808-1493OC CrossRef
Metadaten
Titel
Obstructive sleep apnea and cardiovascular disease: a cause more silent than apparent?
verfasst von
Dr. Sven Stieglitz
Hans Jürgen Heppner
Antonio Esquinas
Publikationsdatum
26.08.2019
Verlag
Springer Medizin
Erschienen in
Somnologie / Ausgabe 4/2019
Print ISSN: 1432-9123
Elektronische ISSN: 1439-054X
DOI
https://doi.org/10.1007/s11818-019-0213-9

Weitere Artikel der Ausgabe 4/2019

Somnologie 4/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.